Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway.

Saved in:
Bibliographic Details
Title: Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway.
Authors: Premkumar DR; Department of Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA., Jane EP, Foster KA, Pollack IF
Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2013 Aug; Vol. 346 (2), pp. 201-10. Date of Electronic Publication: 2013 Jun 05.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1521-0103
DOI:10.1124/jpet.113.204743